| scholarly article | Q13442814 |
| P2093 | author name string | Jong Chul Rhee | |
| Do Young Kim | |||
| Hyuk Lee | |||
| Seung Woon Paik | |||
| Kwang Cheol Koh | |||
| Moon Seok Choi | |||
| Jeong Hwan Kim | |||
| Byung Chul Yoo | |||
| Joon Hyoek Lee | |||
| Soon Mi Song | |||
| P433 | issue | 1 | |
| P921 | main subject | chronic hepatitis C | Q55779873 |
| peginterferon alfa-2a | Q420056 | ||
| ribavirin | Q421862 | ||
| P304 | page(s) | 31-40 | |
| P577 | publication date | 2006-03-01 | |
| P1433 | published in | The Korean journal of hepatology | Q27720798 |
| P1476 | title | Peginterferon alfa-2a plus ribavirin for initial treatment of chronic hepatitis C in Korea | |
| P478 | volume | 12 |
| Q36306694 | A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C. |
| Q37320943 | Assessment of the efficacy of reducing peginterferon alpha-2a and ribavirin dose on virologic response in Koreans with chronic hepatitis C. |
| Q41912262 | Body mass index and nonresponse to antiviral treatment in korean patients with genotype 2 and 3 chronic hepatitis C. |
| Q35833159 | Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus |
| Q35778355 | Efficacy and tolerability of peginterferon alpha plus ribavirin in the routine daily treatment of chronic hepatitis C patients in Korea: a multi-center, retrospective observational study |
| Q33867243 | IL28B SNP rs12979860 is a critical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype-1 infection |
| Q36012993 | IL28B favorable genotype and ultrarapid viral response as the earliest treatment predictors of a sustained viral response in a Georgian cohort infected with the hepatitis C genotype 1. |
| Q38433971 | Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virological response by pegylated interferon and ribavirin |
| Q35153869 | Meta-analysis: superior treatment response in Asian patients with hepatitis C virus genotype 6 versus genotype 1 with pegylated interferon and ribavirin |
| Q33559298 | Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa |
| Q89448325 | Real-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin Dose |
| Q55690522 | Role of vitamin D in chronic hepatitis C. |
| Q40706760 | The virological response in Koreans infected with HCV genotype 1 did not differ between groups treated with a full dose or reduced dose (≥80 % full dose) of peginterferon alfa-2a: a prospective randomized multicenter trial. |
Search more.